David Lovejoy
Keine laufenden Positionen mehr
Vermögen: 49 104 $ am 31.05.2024
Karriereverlauf von David Lovejoy
Ehemalige bekannte Positionen von David Lovejoy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Toronto | Corporate Officer/Principal | - | - |
| PROTAGENIC THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.02.1994 | - |
| Gründer | 03.02.1994 | - | |
Protagenic Therapeutics, Inc. /Old/
 Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von David Lovejoy
| University of Victoria | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Kanada | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Protagenic Therapeutics, Inc. /Old/
Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- David Lovejoy
- Erfahrung
